Botulinum injection for the management of myofascial pain in the masticatory muscles. A prospective outcome study

Sidebottom, Andrew J.; Patel, Amish; Amin, Janaki

doi:10.1016/j.bjoms.2012.07.002

Cited by 69 publications

(59 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Portanto, o tratamento com a BTX-A não pode ser considerado curativo, mas uma abordagem paliativa e sintomática para a gestão de um problema 20 . A BTX-A tem sido amplamente utilizada na odontologia para o tratamento de hiperfunção muscular como é o caso do sorriso gengival, além de desordens temporomandibulares, assimetrias faciais, hipertrofia massetérica, espasmo hemifacial, dor miofascial, sialorréia e bruxismo [21][22][23] . Uma grande vantagem dessa abordagem de tratamento é que é 100% reversível, assim, se houver qualquer aspecto de mudança de aparência sobre a qual o paciente não esteja contente, ele pode ter certeza de que o efeito é temporário 21 .…”

Section: Toxina Botulínica Tipo a (Btx-a)unclassified

Tratamento do sorriso gengival com toxina botulínica tipo A: relato de caso

Magro¹,

Calza²,

Lauxen³

et al. 2015

Rev. da Fac. de Odontologia, UPF

View full text Add to dashboard Cite

IntroduçãoO sorriso de um paciente pode exprimir sensação de alegria, êxito, sensualidade, afeto, cortesia. Um sorriso é mais que uma forma de comunicação, ele é meio de socialização e atração. É indiscutível que a profissão que mais convive com e manipula sorrisos é a Odontologia. Entretanto, frequentemente, cirurgiões-dentistas (CDs), especialistas ou não, negligenciam em seus planejamentos considerações fundamentais a respeito dos padrões de sorriso 1 . Do ponto de vista anatômico e fisiológico, o sorriso é o resultado da exposição dos dentes e da gengiva durante a contração dos grupos musculares dos terços médio e inferior da face 2 . Um sorriso harmônico é determinado não só pela forma, posição e cor dos dentes, mas também pelo tecido gengival 3 . O primeiro passo para estabelecer um diagnós-tico correto de um sorriso harmônico é classificar adequadamente o nível gengival, respeitando-se variáveis, como gênero, idade e saúde periodontal. Uma vez determinada a anormalidade do nível do sorriso, o estabelecimento da sua etiologia é impres-

show abstract

Section: Toxina Botulínica Tipo a (Btx-a)unclassified

Tratamento do sorriso gengival com toxina botulínica tipo A: relato de caso

Magro¹,

Calza²,

Lauxen³

et al. 2015

Rev. da Fac. de Odontologia, UPF

View full text Add to dashboard Cite

show abstract

“…The latter causes localized muscle paralysis for up to 6 months and reduces pain measured using a visual analog scale by at least 25% in 79% patients (32).…”

Section: Local Anesthetic and Steroid Injectionsmentioning

confidence: 99%

Management of the temporomandibular joint in inflammatory arthritis: Involvement of surgical procedures

O’Connor¹,

Fawthrop

Salha

et al. 2017

Eur J Rheumatol

View full text Add to dashboard Cite

IntroductionThe incidence of temporomandibular joint (TMJ) involvement in inflammatory arthritis is often underestimated, and experience in treatment among rheumatologists is limited. Three conditions have an affinity toward the TMJ: Rheumatoid arthritis (RA), psoriatic arthritis (PA), and ankylosing spondylitis (AS). The prevalence is the highest in RA, followed by PA (1-5).The disease processes differ from those seen in osteoarthritis or following trauma, which are characterized by degeneration or ankylosis, respectively, as joint destruction occurs. Furthermore, inflammatory arthropathies are systemic diseases that can lead to a relapse in symptoms, despite initially successful treatment, as TMJ inflammation continues. Immunosuppressive therapies used to ameliorate systemic inflammation may also complicate treatment responses, particularly if surgical management is required, as there is a theoretical increased risk of infection. In contrast, osteoarthritis symptoms may stabilize, previous joint trauma tends not to deteriorate unless TMJ ankylosis ensues, and immunosuppression is not required. Therefore, a different management approach is required in patients with inflammatory arthropathy that addresses both the systemic illness and localized TMJ disease.Pain, reduced mouth opening, joint noises, locking, and difficulty eating are the predominant symptoms and can be debilitating if left untreated. Pain originates from the TMJ itself, the associated masticatory muscles, or from both these areas, and it is manifested by tenderness on palpation of the respective anatomical area. Mouth opening is measured as the gap between the tips of the upper and lower incisors at maximal opening (interincisal distance) with less than 35 mm considered abnormal (6). Joint noises and locking result from the internal derangement of the joint mechanism, which consists of the mandibular condyle, intra-articular disc, and glenoid fossa, or from inflammatory debris deposited as part of the disease process. Combined with pain and restricted opening, these contribute toward problems in eating. 151Many conditions may affect the temporomandibular joint (TMJ), but its incidence in individual joint diseases is low. However, inflammatory arthropathies, particularly rheumatoid and psoriatic arthritis and ankylosing spondylitis, appear to have a propensity for affecting the joint. Symptoms include pain, restriction in mouth opening, locking, and noises, which together can lead to significant impairment. Jaw rest, a soft diet, a bite splint, and medical therapy, including disease-modifying antirheumatic drugs (DMARDs) and simple analgesia, are the bedrock of initial treatment and will improve most symptoms in most patients. Symptom deterioration does not necessarily follow disease progression, but when it does, TMJ arthroscopy and arthrocentesis can help modulate pain, increase mouth opening, and relieve locking. These minimally invasive procedures have few complications and can be repeated. Operations to repair or remove a damaged in...

show abstract

“…Research has certainly shown that Botox and Dysport achieve successful treatment for many facial, TMD and oral dysfunctions which originate from the musculature [71]. Sidebottom et al in their prospective study concluded that BTX is a valuable alternative second line treatment for masticatory myofascial pain when conservative measures have failed [72].…”

Section: Myofascial Painmentioning

confidence: 99%

The Emerging Role of Botulinum Toxin in the Treatment of Orofacial Disorders: Literature Update

Kumar

2017

Asian J Pharm Clin Res

View full text Add to dashboard Cite

Botulinum toxin (BTX) is a lethal neurotoxin produced by Gram-positive anaerobic bacterium called Clostridium botulinum. It is the first toxin used for therapeutic purposes since 1989. BTX treatment is relatively safe and efficacious, less invasive, conservative, and the effects are faster and reversible. The purpose of this article is to review the literature regarding the applications of BTX in the treatment of various orofacial disorders, their mechanism of action, contraindications, and complications. From the recently published literature, it is clear that the role of BTX as a therapeutic agent for several conditions is expanding. With the training of BTX-A injection techniques and adequate knowledge about treatment protocols, general dentists can safely administer BTX injections. The ability to use Botox as an adjuvant and primary mode of the treatment for various maxillofacial disorders offers exciting treatment options for dentists and patients in the future.

show abstract

Botulinum injection for the management of myofascial pain in the masticatory muscles. A prospective outcome study

Cited by 69 publications

References 19 publications

Tratamento do sorriso gengival com toxina botulínica tipo A: relato de caso

Tratamento do sorriso gengival com toxina botulínica tipo A: relato de caso

Management of the temporomandibular joint in inflammatory arthritis: Involvement of surgical procedures

The Emerging Role of Botulinum Toxin in the Treatment of Orofacial Disorders: Literature Update

Contact Info

Product

Resources

About